.FDA turns down psychedelic MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Permit MDMA Therapy, Looking For More Study The New York TimesFDA Rejects Ecstasy-Based Medication The Commercial JournalFDA refuses to accept unique MDMA therapy to alleviate post-traumatic stress disorder, with ask for additional litigation records CNNFDA refuses initially experimental to treat post-traumatic stress disorder, asking for more research study The Washington Message.